Evidence map›Paper›PMID 29182598›Full record

ArticleScientific data2017

Monitoring transcription initiation activities in rat and dog.

Marina Lizio, Abdul Kadir Mukarram, Mizuho Ohno, Shoko Watanabe, Masayoshi Itoh, Akira Hasegawa, Timo Lassmann, Jessica Severin, Jayson Harshbarger, Imad Abugessaisa and 6 more

Open access · goldAbstract readDataset
In one paragraph

Article in Scientific data, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Prediction of Enhancer RNAs in Chicken Genome.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Genome-to-phenome research in rats: progress and perspectives.International journal of biological sciences · 2021
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 5 countries.

Marina LizioRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.ORCID 0000-0001-7337-7325
Abdul Kadir MukarramDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm SE-171 76, Sweden.
Mizuho OhnoRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.
Shoko WatanabeRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.
Masayoshi ItohRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.
Akira HasegawaRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.
Timo LassmannRIKEN Yokohama Institute, Omics Science Center, Yokohama 230-0045, Japan.
Jessica SeverinRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.
Jayson HarshbargerRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.
Imad AbugessaisaRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.ORCID 0000-0001-7458-801X
Takeya KasukawaRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.ORCID 0000-0001-5085-0802
Chung Chau HonRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.ORCID 0000-0002-3741-7577
Piero CarninciRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.
Yoshihide HayashizakiRIKEN Yokohama Institute, Omics Science Center, Yokohama 230-0045, Japan.
Alistair R R ForrestRIKEN Yokohama Institute, Omics Science Center, Yokohama 230-0045, Japan.
Hideya KawajiRIKEN Center for Life Science Technologies, Division of Genomic Technologies, Yokohama 230-0045, Japan.ORCID 0000-0002-0575-0308
CE Technologies (United Kingdom) · GBRIKEN · JPHarry Perkins Institute of Medical Research · AUKarolinska Institutet · SEThe Kids Research Institute Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The promoter landscape of several non-human model organisms is far from complete. As a part of FANTOM5 data collection, we generated 13 profiles of transcription initiation activities in dog and rat aortic smooth muscle cells, mesenchymal stem cells and hepatocytes by employing CAGE (Cap Analysis of Gene Expression) technology combined with single molecule sequencing. Our analyses show that the CAGE profiles recapitulate known transcription start sites (TSSs) consistently, in addition to uncover novel TSSs. Our dataset can be thus used with high confidence to support gene annotation in dog and rat species. We identified 28,497 and 23,147 CAGE peaks, or promoter regions, for rat and dog respectively, and associated them to known genes. This approach could be seen as a standard method for improvement of existing gene models, as well as discovery of novel genes. Given that the FANTOM5 data collection includes dog and rat matched cell types in human and mouse as well, this data would also be useful for cross-species studies.

Indexed as

Transcription, GeneticAnimalsDogsMolecular Sequence AnnotationPromoter Regions, GeneticRatsTranscription Initiation Site

Identifiers

PMID29182598
PMCPMC5704677
OpenAlexW2770926404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.